Business Description
MEI Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US55279B3015
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.85 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | 0.51 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -3.65 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.3 | |||||
3-Year EBITDA Growth Rate | 1 | |||||
3-Year EPS without NRI Growth Rate | 2.3 | |||||
3-Year Book Growth Rate | -35.6 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 31.32 | |||||
9-Day RSI | 36.79 | |||||
14-Day RSI | 42.36 | |||||
6-1 Month Momentum % | -19.28 | |||||
12-1 Month Momentum % | -93.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.17 | |||||
Quick Ratio | 6.17 | |||||
Cash Ratio | 5.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | 1.11 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 33.62 | |||||
Net Margin % | 39.18 | |||||
FCF Margin % | -65.58 | |||||
ROE % | 52.13 | |||||
ROA % | 25.84 | |||||
ROIC % | 131.26 | |||||
ROC (Joel Greenblatt) % | 175.13 | |||||
ROCE % | 25.74 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.81 | |||||
PE Ratio without NRI | 0.81 | |||||
PEG Ratio | 0.07 | |||||
PS Ratio | 0.32 | |||||
PB Ratio | 0.42 | |||||
Price-to-Tangible-Book | 0.42 | |||||
EV-to-EBIT | -1.06 | |||||
EV-to-EBITDA | -1.04 | |||||
EV-to-Revenue | -0.35 | |||||
EV-to-FCF | 0.54 | |||||
Price-to-Graham-Number | 0.12 | |||||
Price-to-Net-Current-Asset-Value | 0.54 | |||||
Price-to-Net-Cash | 0.58 | |||||
Earnings Yield (Greenblatt) % | -94.34 | |||||
FCF Yield % | -206.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MEI Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 66.754 | ||
EPS (TTM) ($) | 3.92 | ||
Beta | -1.08 | ||
Volatility % | 79.01 | ||
14-Day RSI | 42.36 | ||
14-Day ATR ($) | 0.076369 | ||
20-Day SMA ($) | 3.370635 | ||
12-1 Month Momentum % | -93.55 | ||
52-Week Range ($) | 2.825 - 55.79 | ||
Shares Outstanding (Mil) | 6.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MEI Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MEI Pharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MEI Pharma Inc Frequently Asked Questions
What is MEI Pharma Inc(LTS:0JW9)'s stock price today?
When is next earnings date of MEI Pharma Inc(LTS:0JW9)?
Does MEI Pharma Inc(LTS:0JW9) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |